Tradestie Institutional Equity Comparison Engine
HHS vs CNCG โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
HHS Overall Edge
HHS Captures Institutional Edge (2โ1 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Harte Hanks, Inc. (HHS) driven by superior Valuation, Growth & Margin while CNCG counters with relative strength in Momentum & Technical. Fundamentally, HHS trades at 14.3x Forward P/E with -3.2% operating margin (-1.7% YoY revenue) versus CNCG at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, HHS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CNCG sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
HHS
HHS 14.3x vs CNCG N/M Fwd P/E
Growth & Margin Winner
HHS
Op Margin -3.2% vs N/A ยท YoY -1.7% vs N/A
Momentum & Technical Winner
CNCG
1Y +8.8% vs +109.8% ยท 52W Pos 69% vs 82%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
HHS
US Equity
Harte Hanks, Inc.
Services-Direct Mail Advertising Services
$3.84
-4.24% 1D
Market Cap
$30.0M
1M Return
-10.49%
1Y Return
+8.78%
Forward P/E
14.3x
Unified AI Score
61.8 / 100
BUY
Tech 76.0
Fund 61.0
Flow 50.0
Mom 54.0
CNCG
US Equity
CNCG
Institutional Equity
$32.28
+0.59% 1D
Market Cap
N/A
1M Return
-6.66%
1Y Return
+109.81%
Forward P/E
N/M
Unified AI Score
56.7 / 100
HOLD
Tech 40.0
Fund 48.0
Flow 50.0
Mom 54.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
HHS +8.78%
CNCG +109.81%
Spread: +143.34 pp (CNCG Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
HHS TTM Op. Margin: -3.2%
CNCG TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HHS vs CNCG. Trailing 12-month operating profitability (HHS -3.2% vs CNCG N/A) and valuation multiples (HHS 14.3x vs CNCG N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | HHS | CNCG | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $30.0M | N/A | Larger Scale | HHS |
| Trailing P/E Ratio Valuation | 14.3x | N/M | Lower Multiple | HHS |
| Forward P/E Ratio Valuation | 14.3x | N/M | Lower Multiple | HHS |
| Revenue Growth (YoY) Growth | -1.7% | N/A | Higher Growth | HHS |
| Operating Margin (TTM) Profitability | -3.2% | N/A | Higher Margin | HHS |
| Net Profit Margin Profitability | -3.7% | N/A | Higher Margin | HHS |
| Return on Equity (ROE) Capital Efficiency | -30.4% | N/A | Higher ROE | HHS |
| 52-Week Range Position Momentum | 69% ($2โ$5) | 82% ($9โ$38) | Stronger Trend | CNCG |
| Beta / 30D Volatility Risk Regime | 0.49ฮฒ ยท 46% Vol | 0.32ฮฒ ยท 78% Vol | Lower Realized Risk | HHS |
| Unified Institutional Score Composite Signal | 61.8 / 100 (BUY) | 56.7 / 100 (HOLD) | Higher Composite | HHS |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full HHS vs CNCG Buy Guide
HHS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
CNCG
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither HHS nor CNCG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.